Takeda Nears First Therapy for Narcolepsy’s Root Cause

Takeda Nears First Therapy for Narcolepsy’s Root Cause

Takeda Pharmaceutical Co.’s experimental narcolepsy drug significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the root cause of the chronic sleep disorder.